Business
Oxford and AstraZeneca resume UK coronavirus vaccine trial – ABC News
Regulators give researchers the green light to continue a study that was suspended when a patient in the UK reportedly suffered a side-effect.
Oxford University has announced it will resume a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca after getting the green light from safety watchdogs.
Key points:
- Globally some 18,000 people have received the trial vaccine
- The vaccine was in late-stage clinical trials in the US, Britain, Brazil and South Africa
- The US was aiming for fast-track approval of a vaccine before November’s presidential election
The late-stage …
Continue Reading
-
Noosa News24 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business21 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News19 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
General22 hours agoTrump threatens Aussie medicines with bitter tax pill